TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY
Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.
Prerequisites & course information
Requisites: MED SC-M 810 , 811 , 812 , and 813 Course Designation: Grad 50% - Counts toward 50% graduate coursework requirement Repeatable for Credit: No Last Taught: Fall 2026 Learning Outcomes: 1. Demonstrate understanding of innate and adaptive immune interactions with tumors Audience: Graduate 2. Apply understanding of immunology to understand immunotherapeutic approaches in cancer Audience: Graduate 3. Compare and contrast therapeutic mechanisms of diverse immunotherapies Audience: Graduate 4. Demonstrate knowledge of the patterns and rates of response to immunotherapies among distinct cancers Audience: Graduate 5. Demonstrate understanding of immunotherapy toxicities and approaches to treating these Audience: Graduate 6. Apply and adapt understanding of tumor immunology and current immunotherapies to devise a proposal for next generation approach to cancer immunotherapy Audience: Graduate Learning Outcomes: 1. Demonstrate understanding of innate and adaptive immune interactions with tumors Audience: Graduate 2. Apply understanding of immunology to understand immunotherapeutic approaches in cancer Audience: Graduate 3. Compare and contrast therapeutic mechanisms of diverse immunotherapies Audience: Graduate 4. Demonstrate knowledge of the patterns and rates of response to immunotherapies among distinct cancers Audience: Graduate 5. Demonstrate understanding of immunotherapy toxicities and approaches to treating these Audience: Graduate 6. Apply and adapt understanding of tumor immunology and current immunotherapies to devise a proposal for next generation approach to cancer immunotherapy Audience: Graduate
Sources
- Course catalogue ↗2026-2027